FDA designation provides potentially seven years of market exclusivity after approval and expanded partnering opportunities for tecarfarin PONTE VEDRA, Fla., April 9, 2024 /PRNewswire/ -- Cadrenal ...
Research and Markets has announced the addition of the "Ventricular Assistance Devices Global Market - Forecast to 2023" report to their offering. The heart conditions are considered advanced or end ...
NEW ORLEANS, Nov. 9 - A heart ventricular assist device (VAD) is used as a bridge to organ transplantation, maintaining a patient's cardiac function until a donor organ becomes available. In some ...
Within the last 24 months, I have financial relationship(s) or affiliation(s) with a manufacturer, marketer, reseller, or distributor of a healthcare product or service involved in the management of ...
New York, April 23, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Ventricular Assist Device Market - Premium Insight, Competitive News Feed Analysis, Company ...